BioTech Scout

Discover the most promising early-stage companies in life sciences, scouted by BioPharmaTrend. Follow company news and important business events.

back to Directory


Iktos logo



AI Companies (Drug Discovery)

Iktos is a French start-up company which develops a truly innovative and disruptive artificial intelligence technology for ligand-based de novo drug design, focusing on MPO (multi parametric optimization).
Our innovative algorithm is based on state of the art deep learning models, called generative models, and enables to design new, druggable and synthesizable molecules under the constraint of a given blueprint, with unprecedented speed and performance.

Multi-Parametric Optimization de novo drug design deep learning


Posts Mentioning This Company

AI Drug Discovery Financing Roundup: Unlearn.AI, Iktos, DenovAI, and More

The role of artificial intelligence (AI) in drug discovery is rapidly increasing, since it was shown to be able to expedite R&D process, reduce costs, and provide novel research insights via big data and pattern recognition. AI has found numerous use cases in drug discovery, including target discovery, hit identification, …